These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 17967933)
1. Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells. Acharya P; O'Connor MP; Polli JW; Ayrton A; Ellens H; Bentz J Drug Metab Dispos; 2008 Feb; 36(2):452-60. PubMed ID: 17967933 [TBL] [Abstract][Full Text] [Related]
2. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites. Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072 [TBL] [Abstract][Full Text] [Related]
3. Fitting the elementary rate constants of the P-gp transporter network in the hMDR1-MDCK confluent cell monolayer using a particle swarm algorithm. Agnani D; Acharya P; Martinez E; Tran TT; Abraham F; Tobin F; Ellens H; Bentz J PLoS One; 2011; 6(10):e25086. PubMed ID: 22028772 [TBL] [Abstract][Full Text] [Related]
4. Extrapolation of Elementary Rate Constants of P-glycoprotein-Mediated Transport from MDCKII-hMDR1-NKI to Caco-2 Cells. Meng Z; Ellens H; Bentz J Drug Metab Dispos; 2017 Feb; 45(2):190-197. PubMed ID: 27856526 [TBL] [Abstract][Full Text] [Related]
5. Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp. Lumen AA; Li L; Li J; Ahmed Z; Meng Z; Owen A; Ellens H; Hidalgo IJ; Bentz J PLoS One; 2013; 8(8):e69394. PubMed ID: 23976943 [TBL] [Abstract][Full Text] [Related]
6. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Taub ME; Podila L; Ely D; Almeida I Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365 [TBL] [Abstract][Full Text] [Related]
7. If the KI is defined by the free energy of binding to P-glycoprotein, which kinetic parameters define the IC50 for the Madin-Darby canine kidney II cell line overexpressing human multidrug resistance 1 confluent cell monolayer? Lumen AA; Acharya P; Polli JW; Ayrton A; Ellens H; Bentz J Drug Metab Dispos; 2010 Feb; 38(2):260-9. PubMed ID: 19889884 [TBL] [Abstract][Full Text] [Related]
8. The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells. Tran TT; Mittal A; Aldinger T; Polli JW; Ayrton A; Ellens H; Bentz J Biophys J; 2005 Jan; 88(1):715-38. PubMed ID: 15501934 [TBL] [Abstract][Full Text] [Related]
9. Comparison of drug efflux transport kinetics in various blood-brain barrier models. Bachmeier CJ; Trickler WJ; Miller DW Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372 [TBL] [Abstract][Full Text] [Related]
10. A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay. Balimane PV; Chong S Int J Pharm; 2005 Sep; 301(1-2):80-8. PubMed ID: 16023314 [TBL] [Abstract][Full Text] [Related]
11. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). Tanigawara Y; Okamura N; Hirai M; Yasuhara M; Ueda K; Kioka N; Komano T; Hori R J Pharmacol Exp Ther; 1992 Nov; 263(2):840-5. PubMed ID: 1359120 [TBL] [Abstract][Full Text] [Related]
12. The steady-state Michaelis-Menten analysis of P-glycoprotein mediated transport through a confluent cell monolayer cannot predict the correct Michaelis constant Km. Bentz J; Tran TT; Polli JW; Ayrton A; Ellens H Pharm Res; 2005 Oct; 22(10):1667-77. PubMed ID: 16180124 [TBL] [Abstract][Full Text] [Related]
13. Case Study 8: Status of the Structural Mass Action Kinetic Model of P-gp-Mediated Transport Through Confluent Cell Monolayers. Bentz J; Ellens H Methods Mol Biol; 2021; 2342():737-763. PubMed ID: 34272715 [TBL] [Abstract][Full Text] [Related]
14. Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein. Keogh JP; Kunta JR Eur J Pharm Sci; 2006 Apr; 27(5):543-54. PubMed ID: 16406207 [TBL] [Abstract][Full Text] [Related]
15. Caco-2 cell methodology and inhibition of the P-glycoprotein transport of digoxin by Aloe vera juice. Djuv A; Nilsen OG Phytother Res; 2008 Dec; 22(12):1623-8. PubMed ID: 19003953 [TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein. Woodahl EL; Yang Z; Bui T; Shen DD; Ho RJ J Pharmacol Exp Ther; 2004 Sep; 310(3):1199-207. PubMed ID: 15100388 [TBL] [Abstract][Full Text] [Related]
17. Role of P-glycoprotein and the intestine in the excretion of DPC 333 [(2R)-2-{(3R)-3-amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl]-2-oxopyrrolidin-1-yl}-N-hydroxy-4-methylpentanamide] in rodents. Garner CE; Solon E; Lai CM; Lin J; Luo G; Jones K; Duan J; Decicco CP; Maduskuie T; Mercer SE; Gan LS; Qian M; Prakash S; Shen HS; Lee FW Drug Metab Dispos; 2008 Jun; 36(6):1102-10. PubMed ID: 18347085 [TBL] [Abstract][Full Text] [Related]
18. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport. Varma MV; Sateesh K; Panchagnula R Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173 [TBL] [Abstract][Full Text] [Related]
19. A structural model for the mass action kinetic analysis of P-gp mediated transport through confluent cell monolayers. Bentz J; Ellens H Methods Mol Biol; 2014; 1113():289-316. PubMed ID: 24523118 [TBL] [Abstract][Full Text] [Related]
20. Derivation of a System-Independent Chaudhry A; Chung G; Lynn A; Yalvigi A; Brown C; Ellens H; O'Connor M; Lee C; Bentz J Drug Metab Dispos; 2018 Mar; 46(3):279-290. PubMed ID: 29317410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]